• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Merial unveils equine WNV vaccine

February 1, 2004

Merial has released a new equine vaccine ? Recombitek? Equine West Nile Virus (WNV) vaccine.

Merial has released a new equine vaccine Recombitek Equine West Nile Virus (WNV) vaccine.The recent USDA approval of Recombitek Equine West Nile Virus vaccine offers veterinarians a unique product backed by cutting-edge science to yield fast-acting and long-lasting protection from the often-deadly virus, the company says.The Recombitek West Nile Virus vaccine uses recombinant DNA technology to stimulate a fast, multifaceted and long-lasting immune response proven by natural mosquito challenge of West Nile Virus, says Dr. Mike Murray, Merial equine technical director for strategic development. The fast-acting immune response was demonstrated in a controlled trial that showed horses were protected from viremia caused by West Nile Virus infection when challenged as early as two weeks after completion of the two-vaccination series.According to Merial, the benefits of recombinant vaccine technology include a fast, multifaceted (humoral and cell-mediated) immune response, targeted antigen presentation, and a level of safety inherent to this technology because there is no possibility of live virus replication.Recombinant technology vaccines have an intrinsic safety factor because animals receiving the recombinant vaccine are never exposed to the disease-producing organism, Murray says. In 2002, West Nile Virus exploded throughout the U.S. equine population, resulting in 15,257 documented cases, according to Merial. The USDA estimates a mortality rate of approximately one-third of horses showing clinical signs of WNV disease. Although the total number of cases in the United States declined in 2003, WNV presented itself in various geographic regions, including a five-fold increase in clinical cases reported in the Mid-Atlantic states, demonstrating this disease remains dangerous and unpredictable, Merial reports.

For fastest response call (678) 638-3690 or visit the Web site at www.merial.com.

Related Content:

Products
 Vetstoria releases its Fill Rate platform
Vetstoria releases its Fill Rate platform
Communicating the importance of genetic screening
Communicating the importance of genetic screening
Study reveals Zymox Otic Plus is beneficial and effective
Study reveals Zymox Otic Plus is beneficial and effective

Advertisement

Latest News

Texas Tech appoints new faculty member with passion for animal agriculture

Valentine’s Day pet toxins

Newly funded study on chronic hepatitis in Doberman Pinschers

News wrap-up: This week’s headlines, plus learn more about the BlackDVM Network

View More Latest News
Advertisement